Therefore, future research should focus on increasing sample sizes, improving model architectures, and developing more advanced DL models to facilitate the creation of highly efficient intelligent diagnostic tools for KRAS mutation diagnosis in CRC. The gene discussed is KRAS; the disease is colorectal carcinoma.